SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010701
Filing Date
2019-11-12
Accepted
2019-11-12 08:11:18
Documents
59
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nxtc-20190930x10q.htm 10-Q 2031395
2 EX-10.1 nxtc-20190930ex101b27cfe.htm EX-10.1 226752
3 EX-31.1 nxtc-20190930ex31166a71c.htm EX-31.1 13476
4 EX-31.2 nxtc-20190930ex31275738b.htm EX-31.2 12392
5 EX-32.1 nxtc-20190930ex3217b61c4.htm EX-32.1 13682
6 GRAPHIC nxtc20190930ex101b27cfe001.jpg GRAPHIC 22814
  Complete submission text file 0001558370-19-010701.txt   5895469

Data Files

Seq Description Document Type Size
7 EX-101.INS nxtc-20190930.xml EX-101.INS 974300
8 EX-101.SCH nxtc-20190930.xsd EX-101.SCH 38236
9 EX-101.CAL nxtc-20190930_cal.xml EX-101.CAL 45337
10 EX-101.DEF nxtc-20190930_def.xml EX-101.DEF 124730
11 EX-101.LAB nxtc-20190930_lab.xml EX-101.LAB 358368
12 EX-101.PRE nxtc-20190930_pre.xml EX-101.PRE 248163
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38905 | Film No.: 191206285
SIC: 2834 Pharmaceutical Preparations